TickerFactsScreenerDevelopers

Revolution Medicines, Inc. (RVMD) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2017: -$67.72M2018: -$108.42M2019: -$152.57M2020: $474.68M2021: $602.57M2022: $685.19M2023: $1.83B2024: $2.27B2025: $1.63B$1.63B
2017Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$1.63B-28.0%
2024$2.27B+24.0%
2023$1.83B+166.5%
2022$685.19M+13.7%
2021$602.57M+26.9%
2020$474.68M+411.1%
2019-$152.57M-40.7%
2018-$108.42M-60.1%
2017-$67.72M—